Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2010
07/14/2010EP2206494A1 Foamable suspension gel
07/14/2010EP2205630A1 Antibody against anthrax toxins
07/14/2010EP2205283A2 Cholesterol derivatives of inhibitors of viral fusion
07/14/2010EP2205282A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
07/14/2010EP2205280A2 Pharmaceutical formulations
07/14/2010EP2205225A1 Intrinscially fluorescent carbon nanospheres and a process thereof
07/14/2010EP2205222A1 Lyophilized pharmaceutical compositions
07/14/2010EP2205216A1 Composition for controlling lipase catalyzed reactions
07/14/2010EP2205214A2 Oral fast disintegrating tablets
07/14/2010EP1490030B2 Nanoparticulate compositions of angiogenesis inhibitors
07/14/2010EP1200100B1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
07/14/2010EP1079859B1 Bifunctional molecules and therapies based thereon
07/14/2010CN1882508B Process for preparing water soluble diterpenes and their applications
07/14/2010CN101778870A Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use
07/14/2010CN101778642A Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
07/14/2010CN101778631A Method for producing pharmaceutical tablet
07/14/2010CN101778626A Medical composition containing rebamipide
07/14/2010CN101778619A Gel-like composition for external application comprising adenine compound
07/14/2010CN101775399A Asia1 type multi-epitope recombinant vaccine of bovine foot-and-mouth disease viruses and preparation method thereof
07/14/2010CN101775372A Anti-testicle-protein hT279 antibody or antibody fragment and application thereof
07/14/2010CN101775371A Anti-testicle-protein hTSC29 antibody or antibody fragment and application thereof
07/14/2010CN101775145A Quaternary grating material and preparation method and application thereof
07/14/2010CN101775132A Method for refining low-odor polyether polyol
07/14/2010CN101775082A Amphoteric ion-based charge reversal chitosan derivative and application thereof in medicament
07/14/2010CN101774599A Modified na-montmorillonite, preparation method and application thereof
07/14/2010CN101773670A Liquid crystal medicine carrier
07/14/2010CN101773665A Reproductive protective agent facilitating human fertilization
07/14/2010CN101773578A Vitex oil nanoemulsion and preparation method thereof
07/14/2010CN101773546A Salvia miltiorrhiza effective-component synchronous site-specific drug delivery mini-pill and preparation method thereof
07/14/2010CN101773537A Slow-release microspheres prepared from active ingredients of tripterygium wilfordii and preparation method thereof
07/14/2010CN101773518A Medicine for treating infectious diseases
07/14/2010CN101773517A H2S or H2S donator temperature sensitivity instant gel preparation for injection
07/14/2010CN101773515A Preparation methods of creatinine absorbent
07/14/2010CN101773513A Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina
07/14/2010CN101773511A Compound topical combination drug for treatment of acne and preparation method thereof
07/14/2010CN101773509A Glycyrrhizin high-concentration preparation
07/14/2010CN101773508A Stable Trifusal pharmaceutical composition
07/14/2010CN101773506A Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate
07/14/2010CN101773505A Cefpiramide-containing medicine used for injection
07/14/2010CN101773502A Lansoprazole medicine composition and preparation method thereof
07/14/2010CN101773501A Pantoprazole sodium combined medicament and preparation method thereof
07/14/2010CN101773487A Exotic plant Flaveria bidentis active ingredient chlorogenic acid intercalation hydrotalcite and preparation method thereof
07/14/2010CN101773484A Gastric-floating osmotic pump non-homogeneous film capsule controlled release system and preparation method thereof
07/14/2010CN101773483A Preparation method of water-insoluble drug microcapsule
07/14/2010CN101773482A Three-stage pulsed release controlled release tablet and preparation method thereof
07/14/2010CN101773481A Chewable tablet containing montelukast sodium
07/14/2010CN101773479A Method for preparing shell-core double-layer microspheres
07/14/2010CN101773478A Pulmonary targeting microsphere of veterinary ceftiofur hydrochloride and preparation method thereof
07/14/2010CN101773477A Ceftiofur lung targeting microsphere used for beasts and birds and preparation method thereof
07/14/2010CN101773475A Preparation method of capsicine micro spheres
07/14/2010CN101773474A Preparation method of toltrazuril soluble powder
07/14/2010CN101773471A Mitoxantrone targeting sustained-release long-circulating nanometer liposome and preparation method
07/14/2010CN101773470A ivermectin submicron emulsion for injection
07/14/2010CN101773469A Aztreonam/arginine medicament composition suspension injection
07/14/2010CN101773468A Zanamivir nasal nanometer suspension and preparation method thereof
07/14/2010CN101773467A Milbemycin or milbemycin oxime sustained-release injection for animals and preparation method
07/14/2010CN101773466A Oral administration nanometer polymer micelle medicine carrying system and preparation method thereof
07/14/2010CN101773465A Polymer micelle medicine carrying system using amino acid as stabilizing agent
07/14/2010CN101773430A Patch and patch preparation
07/14/2010CN101574325B Sodium dichlorophenolate sustained-release tablet and method for controlling sustained-release of sodium dichlorophenolate sustained-release tablet
07/14/2010CN101574324B Felodipine sustained-release tablet and method for controlling sustained-release of Felodipine sustained-release tablet
07/14/2010CN101518642B Oral liquid preparations
07/14/2010CN101322696B Soft capsules anti-leakage method
07/14/2010CN101244272B Anti-solid tumors pharmaceutical combination containing topological enzyme inhibitor
07/14/2010CN101229188B External medicine for onychomycosis
07/14/2010CN101229157B Calldesartan ci1exetil medicine compounds
07/14/2010CN101181280B Pirarubicin freeze-dry preparations and preparation method thereof
07/14/2010CN101172159B Acidic biological adhesion heat-variable gelling agent, its preparing method and uses
07/14/2010CN101167718B Rebescensine A powder injection and preparing process thereof
07/14/2010CN101138556B Terbinafine or its salt film forming gel composition and uses thereof
07/14/2010CN101130085B Nano montmorillonite for restraining bacterium and method of preparing the same
07/14/2010CN101045037B Cationic elaioplast and its adenovirus composition, its preparing method and use
07/14/2010CN101036642B Ginkgolide B nanometric liposomes medicine and the preparing method thereof
07/14/2010CN101002844B Instant granulated medicine for sobering use and its preparing method
07/13/2010US7754879 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier
07/13/2010US7754876 Method for purification of lactose
07/13/2010US7754774 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
07/13/2010US7754761 Sulfonated compounds and compositions for treating amyloidosis
07/13/2010US7754692 Treating retinopathy both of diabetes and prematurity, or tumor growth
07/13/2010US7754686 fibroblast growth factor (FGF); lyophilization; storage stability
07/13/2010US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
07/13/2010US7754681 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond
07/13/2010US7754678 fusion proteins; drug delivery
07/13/2010US7754420 genetic engineering of a cyanovirin; gene therapy; exogenous gene expression; use alone or in combination with antiviral agents such as AZT; AIDS therapy
07/13/2010US7754255 Bone metabolism improving agent
07/13/2010US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes
07/13/2010US7754239 Envelope of film forming, water soluble polymer enclosing a core; mixture containing plasticizer and acid; food, drugs, oral hygiene, cosmetics
07/13/2010US7754238 Delivery of microparticle-conjugated drugs for inhibition of stenosis
07/13/2010US7754236 polyester-based film substrate have specified surface roughness on the side that a drug-containing adhesive layer is laminated thereon; free from any migration of a drug into a substrate; bonding strength, no adhesive residue when peeled off skin; for narcotic analgesic fentanyl
07/13/2010US7754234 Composition and method of treating a sore throat
07/13/2010US7754229 Comprises biopolymer such as polyhydroxyalkanoate, polylactide, polyglycoside, polylactideglycolide, and polycaprolactone, as particles in suspension in aqueous medium forming a latex, linked to binder; creams
07/13/2010US7754219 by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen
07/13/2010US7754211 Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
07/13/2010CA2572498C Biphasic capsule formulation
07/13/2010CA2538124C Biological active coating components, coatings, and coated surfaces
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/13/2010CA2447030C Immune modulation device for use in animals
07/13/2010CA2445388C Stabilized medicine-releasing compositions
07/13/2010CA2444535C Formoterol/steroid bronchodilating compositions and methods of use thereof
07/13/2010CA2440770C Manufacturing dissolvable dosage forms
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 1712